Last checked at 2 Mar 2017 07:00
EKF Diagnostics Holdings plc
("EKF", the "Company")
Notice of results
Investor results presentation
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its preliminary results for the year ended 31 December 2016 on Tuesday 21 March 2017.
Analyst briefing
A briefing for analysts will take place at 10am on Tuesday 21 March 2017 at the offices of N+1 Singer, One Bartholomew Lane, London EC2N 2AX. To register, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com.
Investor briefing
A briefing for all investors will take place on Tuesday 21 March 2017 at the London Capital Club, 15 Abchurch Lane, EC4N 7BW from 4.30pm for a 4.45pm start, and will be followed by drinks. If you would like to register for the investor presentation, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 |
Julian Baines, CEO | |
Richard Evans, FD & COO | |
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 |
Alex Price / Alex Laughton-Scott | |
Walbrook PR Limited | Tel: 020 7933 8780 or ekf@walbrookpr.com |
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |